Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Costica Aloman

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Hepatology (Baltimore, Md.)|March 4, 2010
Dendritic cells in liver fibrosis: conductor of the inflammatory orchestra?Costica Aloman, Frank Tacke
Journal of Cellular Immunology|July 30, 2021
Murine Models of Alcohol Consumption: Imperfect but Still Potential Source of Novel Biomarkers and Therapeutic Drug Discovery for Alcoholic Liver DiseaseKhaled Alharshawi, Costica Aloman
Hepatology (Baltimore, Md.)|December 6, 2003
Resistance of HBV to adefovir dipivoxil: a case for combination antiviral therapy?Costica Aloman, Jack R Wands
Biochimica Et Biophysica Acta|January 15, 2013
Dendritic cells and liver fibrosisAdeeb H Rahman, Costica Aloman
The American Journal of Gastroenterology|July 1, 2021
Potential Bias and Misconceptions in Liver Transplantation for Alcohol- and Obesity-Related Liver DiseaseJeremy Van, Costica Aloman, Nancy Reau
Alcoholism, Clinical and Experimental Research|February 3, 2011
Dendritic cells in alcoholic liver injury and fibrosisCostica Aloman, Scott L Friedman, Miriam Merad
Current Opinion in Gastroenterology|April 28, 2009
Hepatic fibrosisJingjing Jiao, Scott L Friedman, Costica Aloman
Annals of Hepatology|September 14, 2024
Characterizing outcomes in a large cohort of latinx patients with autoimmune hepatitisEleanor Belilos, Jessica Strzepka, Ethan Ritz, et al.
Gastroenterology|January 30, 2007
Chronic ethanol consumption impairs cellular immune responses against HCV NS5 protein due to dendritic cell dysfunctionCostica Aloman, Stephan Gehring, Philip Wintermeyer, et al.
Hepatology Communications|September 13, 2022
Differential expression of hepatic cancer stemness and hypoxia markers in residual cancer after locoregional therapies for hepatocellular carcinomaMiran Kim, Kam Man Hui, Ming Shi, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Hepatology (Baltimore, Md.)|March 4, 2010
Dendritic cells in liver fibrosis: conductor of the inflammatory orchestra?Costica Aloman, Frank Tacke
Journal of Cellular Immunology|July 30, 2021
Murine Models of Alcohol Consumption: Imperfect but Still Potential Source of Novel Biomarkers and Therapeutic Drug Discovery for Alcoholic Liver DiseaseKhaled Alharshawi, Costica Aloman
Hepatology (Baltimore, Md.)|December 6, 2003
Resistance of HBV to adefovir dipivoxil: a case for combination antiviral therapy?Costica Aloman, Jack R Wands
Biochimica Et Biophysica Acta|January 15, 2013
Dendritic cells and liver fibrosisAdeeb H Rahman, Costica Aloman
The American Journal of Gastroenterology|July 1, 2021
Potential Bias and Misconceptions in Liver Transplantation for Alcohol- and Obesity-Related Liver DiseaseJeremy Van, Costica Aloman, Nancy Reau
Alcoholism, Clinical and Experimental Research|February 3, 2011
Dendritic cells in alcoholic liver injury and fibrosisCostica Aloman, Scott L Friedman, Miriam Merad
Current Opinion in Gastroenterology|April 28, 2009
Hepatic fibrosisJingjing Jiao, Scott L Friedman, Costica Aloman
Annals of Hepatology|September 14, 2024
Characterizing outcomes in a large cohort of latinx patients with autoimmune hepatitisEleanor Belilos, Jessica Strzepka, Ethan Ritz, et al.
Gastroenterology|January 30, 2007
Chronic ethanol consumption impairs cellular immune responses against HCV NS5 protein due to dendritic cell dysfunctionCostica Aloman, Stephan Gehring, Philip Wintermeyer, et al.
Hepatology Communications|September 13, 2022
Differential expression of hepatic cancer stemness and hypoxia markers in residual cancer after locoregional therapies for hepatocellular carcinomaMiran Kim, Kam Man Hui, Ming Shi, et al.
Pageof 6